Back to search
FDAFDA · Food and drugs·Recall number D-1064-2020

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451

Published March 25, 2020 · Recall initiated: March 5, 2020

Summary

FDA records drug Class II recall D-1064-2020, published March 25, 2020 and initiated March 5, 2020. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Terminated; Reported quantity: 32,592 bags; Lot: Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Product was distributed throughout the United States.
Lot
Lot #: 19EG02012, 19EG02019, Exp. Date 05/2020; 19DG02050, Exp. Date 04/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sodium Chloride 0.9% Injection, USP, 1000 mL bags, Rx only, Manufactured by: Fresenius Medical Care North America, Waltham, MA 02451 recalled?

Yes. FDA published recall D-1064-2020 on March 25, 2020. Reported hazard: CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter